Declared this Saturday (23) as a global health emergency, monkeypox often causes rashes on the skin, which spread over the body.
Here are the most common early symptoms:
- muscle aches
- back pain
- swollen nodes (lymph nodes)
Within 1 to 3 days (sometimes longer) after the fever appears, the patient develops a rash, usually starting on the face and spreading to other parts of the body.
Lesions go through five stages before falling off, according to the US Centers for Disease Control (CDC). The illness usually lasts for 2 to 4 weeks.
- How do you know if skin irritation could be the disease?
Microscope image shows monkeypox virus — Photo: Cynthia S. Goldsmith, Russell Regner/CDC via AP
O use of masksO detachment and the sanitization of hands are ways to avoid contagion by monkeypox.
The National Health Surveillance Agency (Anvisa) reinforced the adoption of these measures, stressing that they also serve to protect against Covid-19.
“Such non-pharmacological measures, such as physical distancing whenever possible, the use of protective masks and frequent hand hygiene, have the power to protect the individual and the community not only against Covid-19, but also against other diseases. “, the agency said.
In an interview this Saturday (23), WHO Director-General Tedros Adhanom Ghebreyesus said that, with the tools available, it will be possible to control the outbreak and stop transmission.
There are no specific treatments for monkeypox virus infections, according to the second US Centers for Disease Control (CDC).
However, monkeypox and smallpox viruses are genetically similar, meaning that antiviral drugs and vaccines designed to protect against smallpox can be used to prevent and treat monkeypox virus infections.
Cases in Brazil and in the world
More than 16,000 cases have been reported in 75 countries, said the WHO director-general. The situation is more serious in Europe. In the rest of the world, the risk is relatively moderate. The Ministry of Health counted, until this Thursday (20), 592 cases in Brazil.
Saturday’s decision could lead to greater investment in the treatment of the disease and advance in the fight for vaccines, which are in short supply.
According to the director-general of the WHO, only half of the countries with recorded cases of monkeypox have guaranteed access to vaccines.
The WHO’s director of emergencies, Mike Ryan, says that being vaccinated does not provide instant protection against the disease.